Researchers Stop Parkinson's Symptoms in Mice Using a Copper Supplement. Could Humans Be Next?
Summary by ZME Science
2 Articles
2 Articles
All
Left
Center
1
Right
FDA approves bilateral ultrasound for Parkinson's symptoms
The U.S. Food and Drug Administration has approved Exablate Neuro, Insightec’s platform for noninvasive, MRI-guided focused ultrasound therapy, for the bilateral treatment of motor symptoms in patients with advanced Parkinson’s disease who no longer respond to medication. The therapy targets regions within the pallidothalamic tract, a brain pathway involved in motor control and coordination. Exablate was previously approved for unilateral treatm…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium